[1]钟冬祥 管丽华 周达新.经皮肺动脉成形术在慢性血栓栓塞性肺动脉高压应用中的研究进展[J].心血管病学进展,2019,(5):693-696.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.008]
 ZHONG Dongxiang,GUAN Lihua,ZHOU Daxin.Percutaneous Transluminal Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2019,(5):693-696.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.008]
点击复制

经皮肺动脉成形术在慢性血栓栓塞性肺动脉高压应用中的研究进展()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2019年5期
页码:
693-696
栏目:
综述
出版日期:
2019-08-25

文章信息/Info

Title:
Percutaneous Transluminal Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension
作者:
钟冬祥 管丽华 周达新
(复旦大学附属中山医院心内科,上海 200032 )
Author(s):
ZHONG Dongxiang GUAN Lihua ZHOU Daxin
(Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China)
关键词:
慢性血栓栓塞性肺动脉高压经皮肺动脉成形术
Keywords:
Chronic thromboembolic pulmonary hypertension Percutaneous transluminal pulmonary angioplasty
DOI:
10.16806/j.cnki.issn.1004-3934.2019.05.008
摘要:
慢性血栓栓塞性肺动脉高压是由肺动脉血栓机化并堵塞肺动脉引起的一类严重心肺血管疾病,预后极差。目前的治疗方式主要有药物、肺动脉内膜剥脱术及经皮肺动脉成形术。对于药物治疗效果不佳、无法耐受或不愿意行肺动脉内膜剥脱术的患者,经皮肺动脉成形术提供了一种新的选择。
Abstract:
Chronic thromboembolic pulmonary hypertension is a serious cardiopulmonary vascular disease caused by pulmonary thromboembolization and occlusion of pulmonary artery. Its prognosis is very poor. Current treatments include drugs, pulmonary endarterectomy and percutaneous transluminal pulmonary angioplasty (PTPA). PTPA provides a new option for patients with poor drug efficacy, intolerance or unwillingness to perform pulmonary endarterectomy.

参考文献/References:


[1] Galie N,Humbert M,Vachiery JL,et al. 2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension[J]. Rev Esp Cardiol(Engl Ed),2016,69(2):177.

[2] Jenkins D. Pulmonary endarterectomy:the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension[J]. Eur Respir Rev,2015,24(136):263-271.

[3] Jenkins D,Madani M,Fadel E, et al. Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension[J]. Eur Respir Rev,2017,26(143):160111

[4] Yoshimi S,Tanabe N,Masuda M,et al. Survival and quality of life for patients with peripheral type chronic thromboembolic pulmonary hypertension[J]. Circ J,2008,72(6):958-965.

[5] Piazza G,Goldhaber SZ. Chronic thromboembolic pulmonary hypertension[J]. N Engl J Med,2011,364(4):351-360.

[6] Pepke-Zaba J,Delcroix M,Lang I,et al. Chronic thromboembolic pulmonary hypertension(CTEPH):results from an international prospective registry[J]. Circulation,2011,124(18):1973-1981.

[7] Freed DH,Thomson BM,Berman M,et al. Survival after pulmonary thromboendarterectomy:effect of residual pulmonary hypertension[J].J Thorac Cardiovasc Surg,2011,141(2):383-387.

[8] Mayer E,Jenkins D,Lindner J,et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension:results from an international prospective registry[J]. J Thorac Cardiovasc Surg,2011,141(3):702-710.

[9] Voorburg JA,Cats VM,Buis B,et al. Balloon angioplasty in the treatment of pulmonary hypertension caused by pulmonary embolism[J]. Chest,1988,94(6):1249-1253.

[10] Feinstein JA,Goldhaber SZ,Lock JE,et al. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension[J]. Circulation,2001, 103(1):10-13.

[11] Sugimura K,Fukumoto Y,Satoh K,et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension[J]. Circ J,2012,76(2):485-488.

[12] Kataoka M,Inami T,Hayashida K,et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension[J]. Circ Cardiovasc Interv,2012,5(6):756-762.

[13] Andreassen AK,Ragnarsson A,Gude E,et al. Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension[J]. Heart,2013,99(19):1415-1420.

[14] Shinkura Y,Nakayama K,Yanaka K,et al. Extensive revascularisation by balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension beyond haemodynamic normalisation[J]. EuroIntervention,2018,13(17):2060-2068.

[15] Araszkiewicz A,Darocha S,Pietrasik A,et al. Balloon pulmonary angioplasty for the treatment of residual or recurrent pulmonary hypertension after pulmonary endarterectomy[J]. Int J Cardiol,2019,278:232-237.

[16] Satoh T,Kataoka M,Inami T,et al. Endovascular treatment for chronic pulmonary hypertension:a focus on angioplasty for chronic thromboembolic pulmonary hypertension[J]. Expert Rev Cardiovasc Ther,2016,14(9):1089-1094.

[17] Kim NH,Delcroix M,Jenkins DP,et al. Chronic thromboembolic pulmonary hypertension[J]. J Am Coll Cardiol,2013,62(25 Suppl):D92-D99.

[18] Inami T,Kataoka M,Shimura N,et al. Pressure-wire-guided percutaneous transluminal pulmonary angioplasty:a breakthrough in catheter-interventional therapy for chronic thromboembolic pulmonary hypertension[J]. JACC Cardiovasc Interv,2014,7(11):1297-1306.

[19] Roik M,Wretowski D,Labyk A,et al. Optical coherence tomography of inoperable chronic thromboembolic pulmonary hypertension treated with refined balloon pulmonary angioplasty[J]. Pol Arch Med Wewn,2014,124(12):742-743.

[20] Mizoguchi H,Ogawa A,Munemasa M,et al. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension[J]. Circ Cardiovasc Interv,2012,5(6):748-755.

[21] Auger WR,Fedullo PF,Moser KM,et al. Chronic major-vessel thromboembolic pulmonary artery obstruction:appearance at angiography[J]. Radiology,1992,182(2):393-398.

[22] Inami T,Kataoka M,Shimura N,et al. Pulmonary edema predictive scoring index (PEPSI),a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty[J]. JACC Cardiovasc Interv,2013,6(7):725-736.

[23] Jorge E,Baptista R,Calisto J,et al. Optical coherence tomography of the pulmonary arteries:a systematic review[J]. J Cardiol,2016,67(1):6-14.

[24] Ishiguro H,Kataoka M,Inami T,et al. Diversity of lesion morphology in CTEPH analyzed by OCT,pressure wire,and angiography[J]. JACC Cardiovasc Imaging,2016,9(3):324-325.

[25] Inami T,Kataoka M,Shimura N,et al. Incidence,avoidance,and management of pulmonary artery injuries in percutaneous transluminal pulmonary angioplasty[J]. Int J Cardiol,2015,201:35-37.

相似文献/References:

[1]郭晓曦,综述,张慧敏,等.慢性血栓栓塞性肺动脉高压[J].心血管病学进展,2016,(3):323.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.029]
 GUO Xiaoxi,ZHANG Huimin.Chronic Thromboembolic Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2016,(5):323.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.029]
[2]王高峰 管丽华 周达新.慢性血栓栓塞性肺动脉高压新治疗方法的进展[J].心血管病学进展,2022,(1):14.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.004]
 WANG Gaofeng,GUAN Lihua,ZHOU Daxin.Chronic Thromboembolic Pulmonary HypertensionEvolving Therapeutic Approaches[J].Advances in Cardiovascular Diseases,2022,(5):14.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.004]
[3]胡美曦 黄志华 柳志红 赵智慧 罗勤 赵青.慢性血栓栓塞性肺动脉高压:构建动物模型的研究进展[J].心血管病学进展,2022,(3):236.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
 HU Meixi,HUANG Zhihua,LIU Zhihong,et al.Chronic Thromboembolic Pulmonary Hypertension: Advances in Constructing Animal Models[J].Advances in Cardiovascular Diseases,2022,(5):236.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]

备注/Memo

备注/Memo:
基金项目:上海市科委基金(14ZR1406700)
更新日期/Last Update: 2019-12-23